Erweiterte Informationen für Ärzte


Stereotactic Ablative Body Radiotherapy for Lung Metastases: Where is the Evidence and What are We Doing With It?

Seminars in Radiation Oncology  July 2017Volume 27, Issue 3, Pages 229–239

Salvage robotic SBRT for local prostate cancer recurrence after radiotherapy: preliminary results of the Oscar Lambret Center
Radiation Oncology 2017 12:95

Expert consensus on re-irradiation for recurrent glioma

Radiation Oncology 2017 12:194

Stereotactic Ablative Radiation Therapy is Highly Safe and Effective for Elderly Patients With Early-stage Non-Small Cell Lung Cancer

IJROBP July 15, 2017  Volume 98, Issue 4, Pages 900–907

SBRT for early-stage non-small cell lung cancer- Executive Summary of an ASTRO Evidence-Based Guideline

Practical Radiation Oncology (2017,  7  , 295-301

ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer.

Radiother Oncol. 2017 Jul;124(1):11-17. doi: 10.1016/j.radonc.2017.05.012. Epub 2017 Jul 4.

Institutional analysis of stereotactic body radiotherapy (SBRT) for oligometastatic lymph node metastases

Radiation Oncology 2017 12:105

Dose escalation of Stereotactic Body Radiotherapy (SBRT) for locally advanced unresectable pancreatic cancer patients with CyberKnife: protocol of a phase I study

Radiation Oncology Radiation Oncology 2017  12:6